Posts by: Patricia Inacio PhD

Patricia Inacio PhD

Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.

August 8, 2018

Simple Blood Test Could Determine Best Treatment Option for Advanced Prostate Cancer, Study Says

News

A blood test that examines circulating tumor cells for the presence of the AR-V7 protein could help determine if a patient with advanced prostate cancer would fare better with chemotherapy ... Read more

June 4, 2018

Laser-guided Treatment Better in Long Term than Monitoring for Low-risk Prostate Cancer, New Phase 3 Data Show

News

Prostate cancer patients who undergo a nonsurgical procedure to remove part of their prostate gland — using a kind of photodynamic therapy targeting the blood vessels — fare better in ... Read more

May 7, 2018

Exposure to Blue Light at Night May Increase Risk of Prostate, Breast Cancer, Study Says

News

Exposure to artificial light at night, such as the blue light emitted by most LEDs and computer and smartphone screens, may increase the risk of developing prostate cancer and breast ... Read more

May 3, 2018

New Ultrasound Imaging Technique Detects Prostate Cancer with More Accuracy, Study Says

News

A variation of ultrasound imaging, called shear wave elastography (SWE), may help detect signs of prostate cancer with higher accuracy and reliability than current methods, according to new research. The ... Read more

April 9, 2018April 9, 2018

Focal Ultrasound Prostate Ablation Shows Promising Results with Fewer Side Effects

News

A procedure that eliminates only the diseased part of the prostate in prostate cancer patients has shown promising results while causing fewer side effects, including incontinence and impotence, compared to traditional ... Read more

February 16, 2018February 16, 2018

First Therapy for Non-metastatic, Castration-resistant Prostate Cancer Patients Approved in US

News

The U.S. Food and Drug Administration (FDA) approved Johnson & Johnson’s Erleada (apalutamide), a next-generation androgen receptor inhibitor, as therapy for patients with localized (non-metastatic) prostate cancer who failed to respond ... Read more

February 2, 2018

New Compounds May Counteract Chemotherapy Resistance in Prostate Cancer Cells

News

Researchers at Southern Methodist University discovered three new small molecules that overcome the resistance to chemotherapy observed in patients with prostate, breast, and ovarian cancer. The study, “Targeted inhibitors of P-glycoprotein ... Read more

January 22, 2018

High-fat Diets May Promote Prostate Cancer Metastasis, Mouse Study Suggests

News

Loss of two tumor suppressor genes – PTEN and PML – in prostate cancer appears to trigger the progression of disease by turning the cells into fat-producing factories, new research ... Read more

January 10, 2018

Radiation Therapy Safe in Prostate Cancer Patients with AUS, Study Suggests

News

Prostate cancer patients who underwent surgery for urinary incontinence and received an artificial urinary sphincter (AUS) may safely undergo radiation therapy without the risk of complications to their urinary aid ... Read more

December 11, 2017

Researchers Link Aggressiveness of Prostate Cancer to Process of RB Gene Loss

News

Researchers found that the mechanism by which a tumor loses a key tumor suppressor, the retinoblastoma or RB gene, influences the aggressiveness of prostate cancer. The study, “Differential impact of ... Read more